I’d guess that Merck unfortunately chose that pathway since they were familiar with the tech and it was similar to a successful program they have for Ebola. I don’t know what type of outreach Generex and NuGenerex utilizes to reach out to large pharma. We have the limited relationship with Merck in supplying Keytruda for the AE37 combination proof of concept, and hopefully once recruiting opens (mostly closed since these are cancer patients) we see that grow into a full partnership for larger studies.

I’m currently waiting to go inside for the dreaded colonoscopy. Real quick- many already have summaries on the CC. There’s lots of great posts. Although I really am impressed to a higher degree on how much had been accomplished on the Covid vaccine without BARDA funding. An entire program was built and progressed right on the verge of an IND.

Also all of the business partnerships Joe has maintained without the ability to raise needed funds. They all believe in his vision.

Ok time for a fun colonoscopy!